It is an actual, not an estimate. They reported a profit before tax of 205m. Net Profit after Tax of 157m. Market Cap of 2.1b less 200m cash is 1.9b AUD.
1900/157 = 12.10
It is from their annual report: Neuren Pharmaceuticals Annual Report 2023 so you can check it yourself.
Yes, if you read what I said. Forward PE is more like 35 depending on the multiplier but there is growth in NA and from 2026 onwards we will be seeing revenue from the EU and Japan.
A total dud is nonsense. And the short report predicted a far lower peak sales number than what we're seeing from NA alone. If we reported a 20-30% decrease in Daybue sales maybe there would be some truth to what you said.
- Forums
- ASX - By Stock
- Ann: Q2 2024 update
It is an actual, not an estimate. They reported a profit before...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.75 |
Change
0.160(1.03%) |
Mkt cap ! $2.013B |
Open | High | Low | Value | Volume |
$15.68 | $16.08 | $15.32 | $5.559M | 351.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 926 | $15.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.88 | 1993 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 926 | 15.750 |
6 | 1726 | 15.730 |
2 | 2116 | 15.720 |
2 | 352 | 15.710 |
2 | 3193 | 15.700 |
Price($) | Vol. | No. |
---|---|---|
15.880 | 1993 | 1 |
15.910 | 1993 | 1 |
15.930 | 1993 | 1 |
15.940 | 964 | 1 |
15.960 | 1993 | 1 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online